FDA Approves Cymbalta for Treatment of Generalized Anxiety Disorder
Phramalive.com - In all studies, Cymbalta significantly improved core anxiety symptoms as measured by the Hamilton Anxiety Scale (HAMA), compared with placebo. In addition, Cymbalta patients reported greater improvement in functional impairment associated with the
Source: www.pharmalive.com
Click here for more information about controlling anxiety disorder
<< Home